Zobrazeno 1 - 10
of 38
pro vyhledávání: '"R L, Jirtle"'
Autor:
R, Das Chakraborty, D, Chakraborty, A J, Bernal, K, Schoch, T D, Howard, E H, Ip, S R, Hooper, M S, Keshavan, R L, Jirtle, V, Shashi
Publikováno v:
Translational Psychiatry
Chromosome 22q11.2 deletion syndrome (22q11DS) is the most common microdeletion syndrome in humans. It is typified by highly variable symptoms, which might be explained by epigenetic regulation of genes in the interval. Using computational algorithms
Autor:
A. F. Purchio, Wilfried Bursch, Bettina Grasl-Kraupp, F. Oberhammer, Roland Sedivy, Rolf Schulte-Hermann, R. L. Jirtle, M. Askari
Publikováno v:
British Journal of Cancer
Cell death by apoptosis is a major determinant of growth of normal tissues and tumours. The present study aimed to elucidate signal factors involved in its regulation. Epithelial cells in control liver, during regression of cyproterone acetate induce
Publikováno v:
Cytogenetic and genome research. 113(1-4)
The epigenetic marks on the IGF2R gene that encodes a receptor responsible for IGF-II degradation consist of differentially methylated DNA in association with multiple modifications on the associated histones. We review these epigenetic marks across
Publikováno v:
Cancer. 86(9)
Plasma transforming growth factor-beta1 (TGFbeta1) levels are increased in many malignancies at the time of diagnosis, including all forms of lung carcinoma. Therefore, the potential use of TGFbeta1 as a plasma marker to predict the long term outcome
Publikováno v:
Cancer research. 59(17)
The M6P/IGF2R gene, encoding the insulin-like growth factor II (IGF-II)/mannose 6-phosphate receptor (IGF2R), is frequently inactivated during carcinogenesis. M6P/IGF2R is postulated to be a tumor suppressor gene due to its ability to bind and degrad
Autor:
G R, Hankins, A T, De Souza, R C, Bentley, M R, Patel, J R, Marks, J D, Iglehart, R L, Jirtle
Publikováno v:
Oncogene. 12(9)
The mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2r) functions in the activation of TGFbeta, a potent growth inhibitor for most cell types, the degradation of the mitogen, IGF2, and the intracellular trafficking of lysosomal enzy
Publikováno v:
Carcinogenesis. 17(1)
Phenobarbital (PB) is a potent tumor promoter in rodent liver. In this study we investigated whether PB selectively promotes a population of initiated cells with reduced levels of transforming growth factor-beta (TGF beta) receptors types I, II and I
Publikováno v:
Oncogene. 10(9)
The mannose 6-phosphate/insulin-like growth factor II receptor (M6P/IGFIIr) is required for the activation of transforming growth factor beta, and previously we have found its expression to be significantly reduced in both rat and human hepatocellula
Publikováno v:
The British journal of radiology. 68(807)
The sensitivity of normal tissues rather than of the tumour usually limits the effectiveness of cancer treatment. The normal tissue side effects from chemotherapy and/or radiotherapy result from both direct cellular loss and the extensive fibrosis th
Publikováno v:
Cancer research. 55(5)
The monoterpenes d-limonene and perillyl alcohol (POH) inhibit the growth of mammary tumors. In this investigation we tested whether POH is also effective in reducing liver tumor growth. Diethylnitrosamine was used to induce liver tumors in male Fisc